<seo title="Bristol Myers Squibb" metakeywords="bristol myers squibb,introduction bristol myers,squibb bristol myers,history bristol myers" metadescription="Bristol Myers Squibb was founded in 1887 by William McLaren Bristol and John Ripley Myers.The company was initially established as a small drugstore in New York City."/>
===Introduction to Bristol Myers Squibb===

Bristol Myers Squibb (BMS) is a global biopharmaceutical company that is dedicated to discovering, developing, and delivering innovative medicines to patients around the world. Founded in 1887, BMS has grown to become one of the world’s leading biopharmaceutical companies, with a presence in more than 150 countries. BMS is committed to developing and delivering innovative medicines that help patients live longer, healthier lives. BMS is also committed to making a positive impact on the communities in which it operates, through its corporate [[Social Responsibility|social responsibility]] initiatives.
===History of Bristol Myers Squibb===

BMS was founded in 1887 by William McLaren Bristol and John Ripley Myers. The company was initially established as a small drugstore in New York City. Over the years, BMS has grown to become a global biopharmaceutical company, with a presence in more than 150 countries. BMS has a long history of innovation and has developed a number of groundbreaking medicines, including the first oral anticoagulant, Coumadin, and the first anti-HIV drug, Videx. BMS has also been a leader in the development of immuno-oncology treatments, such as Opdivo and Yervoy.
===Products and Services Offered by Bristol Myers Squibb===

BMS offers a wide range of products and services, including prescription medicines, over-the-counter medicines, vaccines, and consumer health products. BMS also offers a range of services, such as clinical trials, research and development, and manufacturing. BMS is committed to developing innovative medicines that help patients live longer, healthier lives.
===Financial Performance of Bristol Myers Squibb===

BMS has a strong [[Financial Performance|financial performance]], with revenues of $22.3 billion in 2020. BMS has a strong [[Balance Sheet|balance sheet]], with total assets of $50.3 billion and [[Total Liabilities|total liabilities]] of $25.2 billion. BMS has a strong [[Cash Flow|cash flow]], with [[Operating Cash Flow|operating cash flow]] of $7.2 billion in 2020. BMS also has a strong [[Return On Equity|return on equity]], with a return on equity of 17.3%.
===Bristol Myers Squibb’s Impact on the Pharmaceutical Industry===

BMS has had a significant impact on the pharmaceutical industry. BMS has been a leader in the development of innovative medicines, such as the first oral anticoagulant, Coumadin, and the first anti-HIV drug, Videx. BMS has also been a leader in the development of immuno-oncology treatments, such as Opdivo and Yervoy. BMS has also been a leader in the development of vaccines, such as the Shingrix vaccine for shingles.
===Conclusion===

Bristol Myers Squibb is a global biopharmaceutical company that is dedicated to discovering, developing, and delivering innovative medicines to patients around the world. BMS has a long history of innovation and has developed a number of groundbreaking medicines, including the first oral anticoagulant, Coumadin, and the first anti-HIV drug, Videx. BMS has a strong financial performance, with revenues of $22.3 billion in 2020, and a strong balance